Literature DB >> 25737761

Hypogonadism: Easy to define, hard to diagnose, and controversial to treat.

Joshua Sterling1, Aaron M Bernie2, Ranjith Ramasamy3.   

Abstract

Year:  2015        PMID： 25737761      PMCID： PMC4336035          DOI： 10.5489/cuaj.2416

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  27 in total

1.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

2.  Pre-analytical issues for testosterone and estradiol assays.

Authors:  Hershel Raff; Patrick M Sluss
Journal:  Steroids       Date:  2008-05-21       Impact factor: 2.668

3.  Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men.

Authors:  K W Smith; H A Feldman; J B McKinlay
Journal:  Clin Endocrinol (Oxf)       Date:  2000-12       Impact factor: 3.478

4.  Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study.

Authors:  A Gray; H A Feldman; J B McKinlay; C Longcope
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958

5.  Validation of a screening questionnaire for androgen deficiency in aging males.

Authors:  J E Morley; E Charlton; P Patrick; F E Kaiser; P Cadeau; D McCready; H M Perry
Journal:  Metabolism       Date:  2000-09       Impact factor: 8.694

Review 6.  Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.

Authors:  R A Rey; R P Grinspon; S Gottlieb; T Pasqualini; P Knoblovits; S Aszpis; N Pacenza; J Stewart Usher; I Bergadá; S M Campo
Journal:  Andrology       Date:  2012-10-09       Impact factor: 3.842

7.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

8.  Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?

Authors:  Juan E Blümel; Peter Chedraui; Sebastian A Gili; Alejandra Navarro; Karen Valenzuela; Soledad Vallejo
Journal:  Maturitas       Date:  2009-05-28       Impact factor: 4.342

9.  Performance of Massachusetts Male Aging Study (MMAS) and androgen deficiency in the aging male (ADAM) questionnaires in the prediction of free testosterone in patients aged 40 years or older treated in outpatient regimen.

Authors:  Renan Desimon Cabral; Luciane Busin; Tiago Elias Rosito; Walter José Koff
Journal:  Aging Male       Date:  2014-04-16       Impact factor: 5.892

10.  Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.

Authors:  William D Finkle; Sander Greenland; Gregory K Ridgeway; John L Adams; Melissa A Frasco; Michael B Cook; Joseph F Fraumeni; Robert N Hoover
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240
View more
  6 in total

1.  Ketogenic state improves testosterone serum levels-results from a systematic review and meta-analysis.

Authors:  Chiara Furini; Giorgia Spaggiari; Manuela Simoni; Carla Greco; Daniele Santi
Journal:  Endocrine       Date:  2022-09-23       Impact factor: 3.925

2.  The association between caffeine intake and testosterone: NHANES 2013-2014.

Authors:  Frank E Glover; William Michael Caudle; Francesco Del Giudice; Federico Belladelli; Evan Mulloy; Eniola Lawal; Michael L Eisenberg
Journal:  Nutr J       Date:  2022-05-17       Impact factor: 4.344

Review 3.  The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.

Authors:  Varun S Venkatesh; Mathis Grossmann; Jeffrey D Zajac; Rachel A Davey
Journal:  Obes Rev       Date:  2022-01-27       Impact factor: 10.867

Review 4.  Hypogonadism in Exercising Males: Dysfunction or Adaptive-Regulatory Adjustment?

Authors:  Anthony C Hackney
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-31       Impact factor: 5.555

5.  The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience.

Authors:  Letizia Chiara Pezzaioli; Eugenia Quiros-Roldan; Simone Paghera; Teresa Porcelli; Filippo Maffezzoni; Andrea Delbarba; Melania Degli Antoni; Carlo Cappelli; Francesco Castelli; Alberto Ferlin
Journal:  Infection       Date:  2020-12-08       Impact factor: 3.553

Review 6.  Hypogonadism and urologic surgeries: a narrative review.

Authors:  Kiarad Fendereski; Mohammad Ali Ghaed; Joshua K Calvert; James M Hotaling
Journal:  Transl Androl Urol       Date:  2022-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.